Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > List goes on and on

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Nov 20, 2023 10:05am

253 Views

Post# 35744144

RE:RE:RE:RE:RE:RE:List goes on and on

Pure speculation unfortuately. If true the company is missing a high opportunity by not saying as much in a PR.

However there are the management notes issued with the Q3 financials where the company can provide more comprehensive updates on the phase 2 trial, their development work on other cancer treatments and the vaccine initiative.

Hopefully they use the opportunity wisely.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages